PARIS |
PARIS (Reuters) – French drugmaker Sanofi pronounced on Tuesday that a Zaltrap drug had been authorized for selling in a European Union to provide metastatic colorectal cancer.
The capitulation came after a new late-stage investigate of a drug showed poignant alleviation in presence among patients with colon cancer.
(Reporting By Christian Plumb, Editing by Dominique Vidalon)
